Click image to view it in full size

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due to their use as a primary tool for breast cancer detection. These segments are followed by MRI-CAD, which is mainly used as an adjunct to both mammography and ultrasound in breast imaging.

Analysis of the competitive landscape indicates that the top companies accounted for a combined 95% of the total CAD in breast cancer screening market for 2021. Offering AI-enabled CAD solutions is a growth area observed in the market. Given the market dynamics, trends, and competitive nature, it is important for industry stakeholders to have an overall perspective of the technology segments and workflow. This report offers insightful analysis of CAD in breast cancer screening in the form of a global forecast, regional and technological forecasts and analyses, benchmarking of top competitors, and key growth opportunities for industry participants.